Cucumbers from Florida grower recalled for possible salmonella contamination: What to know
Consumers, retailers and distributors need to check refrigerators and bins for cucumbers.
Dozens of people across several states, including Michigan, have been sickened with salmonella infections linked to cucumbers, according to a Food and Drug Administration (FDA) notice.
A Florida grower is voluntarily recalling cucumbers because of possible salmonella contamination.Health officials from the U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) are investigating the multistate outbreak of 'Salmonella Montevideo' infections. The infections are linked to cucumbers grown by Bedner Growers, Inc. in Boynton Beach, Florida, and distributed by Fresh Start Produce Sales, Inc. of Delray, Florida.
So far, there are 26 cases and 9 people hospitalized reported across 15 states, including Michigan. No deaths have been reported. The FDA's map of cases lists Michigan's case count as 1 to 2. Cucumbers were distributed to retailers, distribution centers, wholesalers and food service distributors from April 29 to May 19, according to the FDA's alert. Those cucumbers distributed before the timeline should be past their shelf life and no longer available, the FDA says.
For distributors, restaurants and retailers who have purchased these cucumbers, the products were labeled as either being 'supers,' 'selects,' or 'plains.' The FDA advises that the restaurants, retailers and distributors who purchased the recalled cucumbers between April 29 and May 19, 2025 notify customers of the potentially contaminated product and health concern.
The FDA advises retailers who have or had a potentially contaminated product to:
Clean and sanitize any areas that could have come into contact with potentially contaminated products.
If the potentially contaminated cucumbers were sold in bulk bins or displays, retailers should discard the contents of the bins and use extra care to clean and sanitize the bins before refilling.
Retailers should contact their supplier if they are unsure if whether they received the potentially contaminated product and discard the contents of the bins, use extra care to clean and sanitize the bins before refilling.
'Consumers may be contacted by their retailers if they purchased recalled cucumbers grown by Bedner Growers,' the FDA says.
Consumers are also advised to:
Throw out cucumbers if you cannot tell or are unsure if they were by Bedner Growers.
When eating out over the next week, ask if cucumbers were from Bedner Growers or Fresh Start Produce Sales, Inc.
Consumers, restaurants, and retailers who purchased or received potentially contaminated products, including wholesale products, should carefully clean and sanitize any surfaces or containers that they touched and follow the FDA's safe handling and cleaning advice to reduce the risk of cross-contamination.
During outbreaks and in general for safe food handling to protect against foodborne illnesses consumers and retailers should follow the FDA steps on its website for to clean, separate, cook and chill. This includes washing hands, sanitizing surfaces, cooking foods to proper temperatures and refrigerating and freezing foods properly.
Salmonella is a bacterium that can cause severe and sometimes fatal infections in those with weakened immune systems, children younger than 5, and adults older than 65.
Symptoms for healthy people include diarrhea (which may be bloody), fever, nausea, vomiting, and abdominal cramps.
Symptoms can start six hours to six days after being infected and last four to seven days, according to the CDC.
If you think you have symptoms of salmonella, especially after eating cucumbers, contact your healthcare provider.
The CDC estimates salmonella bacteria cause more than 1.3 million infections in the United States annually, with most illnesses coming from food.
Contact Detroit Free Press food and restaurant writer Susan Selasky and send food and restaurant news and tips to: sselasky@freepress.com. Follow @SusanMariecooks on Twitter. Subscribe to the Free Press.
This article originally appeared on Detroit Free Press: Cucumber recall in 15 states for possible salmonella includes Michigan
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
VSTM Stock Soars 22% in a Month on Ovarian Cancer Combo Drug Approval
Verastem Oncology VSTM shares rallied 22.2% in a month, primarily driven by the FDA approval of the company's novel combination regimen of avutometinib plus defactinib in early May for treating KRAS mutant recurrent low-grade serous ovarian cancer (LGSOC), a rare and distinct type of ovarian cancer. The FDA's decision came well in advance of the originally expected date of June 30, 2025. The approval was granted under the FDA's accelerated approval pathway and is commercialized in the U.S. market as an oral combination co-pack with the two prescription products, known as 'Avmapki Fakzynja Co-Pack.' Following the FDA approval, Avmapki Fakzynja Co-Pack is the first and only FDA-approved treatment for the LGSOC indication. Per Verastem Oncology, the combo offers a much-needed treatment option for patients and sets a new standard of care for women with recurrent LGSOC with a KRAS mutation. Full approval of the product for this use depends on the detailed evidence of clinical benefit in the follow-up phase III RAMP 301 confirmatory study, which will evaluate the combination in women with and without a KRAS mutation. Year to date, Verastem Oncology stock has surged 64.8% against the industry's 5.8% decline. Image Source: Zacks Investment Research Please note that the FDA's decision was based on the results from VSTM's phase II RAMP 201 study, which evaluated the combination of Avmapki and Fakzynja in adult patients with measurable KRAS-mutated recurrent LGSOC. Per the data readout, a 44% overall response rate was observed in patients treated with the combo therapy, with an acceptable safety profile. Additionally, the median duration of response ranged from 3.3 to 31.1 months in the KRAS mutant population. The Avmapki/Fakzynja combo enjoys the FDA's Breakthrough Therapy designation for the treatment of patients with recurrent LGSOC after one or more prior lines of therapy, including platinum-based chemotherapy, in the United States. Avutometinib alone or in combination with defactinib also enjoys the FDA's Orphan Drug designation for the same indication. Verastem Oncology is also looking to expand the label of its approved avutometinib/defactinib combo therapy beyond LGSOC. Last week, VSTM reported positive updated safety and efficacy results from the phase I/II RAMP 205 study evaluating avutometinib plus defactinib in combination with chemotherapy (gemcitabine and Nab-paclitaxel) for the first-line treatment of metastatic pancreatic ductal adenocarcinoma (PDAC) patients. This has also likely contributed to the stock price rally in the past month. The RAMP 205 study is evaluating 60 patients in five cohorts (12 per cohort) who are receiving one of five dose regimens of avutometinib/defactinib combo with chemotherapy for frontline metastatic PDAC. As of April 25, 2025, patients in the dose level 1 cohort achieved an overall response rate of 83% (eight confirmed and two unconfirmed who remain on treatment). Based on this encouraging outcome, Verastem Oncology selected dose level 1 as the recommended phase II dose. Additionally, it was found that the dose level 1 showed the best response, and overall, 92% of patients across all dose levels achieved tumor shrinkage. The safety profile of the avutometinib/defactinib combo was acceptable across all the treatment cohorts and no new safety signals were identified. Verastem Oncology is currently gearing up to initiate a registrational phase III front-line metastatic PDAC study in 2026. Apart from these indications, the company is simultaneously evaluating avutometinib and defactinib in combination with a KRAS G12C inhibitor, sotorasib, for treating non-small cell lung cancer in a separate mid-stage study. Verastem, Inc. price-consensus-chart | Verastem, Inc. Quote Verastem Oncology currently carries a Zacks Rank #3 (Hold). Some better-ranked stocks in the biotech sector are Bayer BAYRY, Lexicon Pharmaceuticals LXRX and Amarin AMRN, each carrying a Zacks Rank #2 (Buy) at present. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. In the past 60 days, estimates for Bayer's earnings per share have increased from $1.19 to $1.25 for 2025. During the same time, earnings per share have increased from $1.28 to $1.31 for 2026. Year to date, shares of Bayer have gained 45.3%. BAYRY's earnings beat estimates in one of the trailing four quarters, matched twice and missed on the remaining occasion, the average negative surprise being 13.91%. In the past 60 days, estimates for Lexicon's loss per share have narrowed from 37 cents to 32 cents for 2025. During the same time, loss per share estimates for 2026 have narrowed from 35 cents to 31 cents. Year to date, shares of LXRX have lost 6.6%. LXRX's earnings beat estimates in three of the trailing four quarters and missed the same on the remaining occasion, delivering an average surprise of 11.97%. In the past 60 days, estimates for Amarin's loss per share have narrowed from $5.33 to $3.48 for 2025. During the same time, loss per share estimates for 2026 have narrowed from $4.13 to $2.67. Year to date, shares of AMRN have gained 17.1%. AMRN's earnings beat estimates in two of the trailing four quarters, matched once and missed the same on the remaining occasion, delivering an average surprise of 29.11%. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Bayer Aktiengesellschaft (BAYRY) : Free Stock Analysis Report Lexicon Pharmaceuticals, Inc. (LXRX) : Free Stock Analysis Report Amarin Corporation PLC (AMRN) : Free Stock Analysis Report Verastem, Inc. (VSTM) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio
Yahoo
2 hours ago
- Yahoo
Alzheimer's blood test can accurately pick up early symptoms
A new blood test for Alzheimer's disease can accurately detect people with early symptoms, research suggests. Experts from the Mayo Clinic in the US have provided further evidence that blood tests can work to accurately diagnose dementia, by examining two proteins in blood plasma. These proteins – amyloid beta 42/40 and p-tau217 – are associated with amyloid plaque build-up, which is a hallmark of Alzheimer's disease. Researchers found the blood test was highly accurate, with 95% sensitivity, which means it was 95% accurate in picking up people with memory problems, with very few cases missed. It was also 82% for specificity, which means it was also highly accurate in ruling out people without dementia. The study was carried out on more than 500 people in an outpatient memory clinic, meaning it is real-world data. The blood test has already been approved by the Food and Drug Administration regulator in the US. Dr Gregg Day, who led the study in the Alzheimer's and Dementia journal, said the test was as good as more invasive tests currently in use. 'Our study found that blood testing affirmed the diagnosis of Alzheimer's disease with 95% sensitivity and 82% specificity,' he said. 'When performed in the outpatient clinical setting, this is similar to the accuracy of cerebrospinal fluid biomarkers of the disease and is much more convenient and cost-effective.' Overall, researchers found that p-tau217 levels were higher in patients with Alzheimer's disease versus those without the disease. Dr Day said the next steps in the research were to evaluate blood-based testing in more diverse patient populations and people with early Alzheimer's who show no cognitive symptoms. Dr Richard Oakley, associate director for research and innovation at the Alzheimer's Society in the UK, said the results 'suggest this test is very accurate' and could be used alongside other tests and observations from a trained health professional. "This study shows how blood tests are making diagnosis of Alzheimer's disease quicker, easier and more accessible than ever before in a real-world setting," he added. "While focused on Alzheimer's disease, the test was evaluated in people with other types of dementias too, showing that it may help with differentiate causes of cognitive decline – though more research in diverse groups of individuals and in community-based setting is still needed."
Yahoo
2 hours ago
- Yahoo
FDA Expands Cucumber Recall Amid Salmonella Outbreak
"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links."Cucumber recall expands amid Salmonella outbreak. Bedner Growers Inc. cucumbers included in products by various brands are now being recalled. Below, find a list of impacted products. Last month's cucumber recall is expanding amid a Salmonella outbreak. The U.S. Food and Drug Administration (FDA) recently updated the products associated with the original Bedner Growers, Inc. recall to include products that either use the recalled cucumbers in their ingredients or feature the cucumbers under new packaging. According to updated statements shared by the FDA on May 28, 2025, and June 4, 2025, the initial Bedner Growers Inc. recall now also includes the following items (full UPC codes and best-by dates can be found in the initial recall statements): Mai sushi—various sushi rolls and boxes Kings, Isabelle's Kitchen Inc., Maple Avenue Foods—prepackaged salads Supreme Produce—fresh-cut salad and vegetable trays Snowfruit & Snowfox—fresh-cut cucumbers and sushi East Coast Fresh, TOPS, Wellsley Farms, Weis, Ahold, Jack and Olive, Created Fresh, Spring and Sprout—Salads, salsas, and other products that include the salsa made with Bedner Growers cucumbers PennRose Farms—whole cucumbers Marketside—fresh-cut cucumbers Read to Eat and Star Market—Greek salad Ukrop's—marinated cucumber salad Big Y Foods—made-to-order sandwiches, wraps, and paninis TGD Cuts—salsa, hot 6/12 oz. TGD Cuts—salsa, mild 6/12 oz. TGD Cuts—salsa, mild 5lb. TGD Cuts—salsa, mild 5lb. TGD Cuts—cucumber sliced/grape tomato 50/2oz. TGD Cuts—cucumber sliced unpeeled 5lb. TGD Cuts—cucumber sliced unpeeled 50/2oz. TGD Cuts—cucumber spears 50/2oz. These products were sold under various brand names, including Jenny's Classic, Mia, Supreme Produce, and more, at big chain stores like Walmart and Target (see here for a comprehensive list of impacted products), as well as smaller chains, nationwide. According to the original recall statement, the cucumbers from sampling tested positive for Salmonella Montevido. Additional samples taken at the same time and location also came back positive for other strains that the FDA believes are unrelated to the current outbreak that, as of press time, have sickened 45 and sent 16 to the hospital. According to the Mayo Clinic, symptoms of a salmonella infection—also known as salmonellosis, and involves the intestinal tract—may range from mild to severe. While some people who develop salmonellosis may have no symptoms at all, others may experience more moderate symptoms, which may include diarrhea, stomach cramps, and fever. Those with more severe symptoms may experience dehydration as a result of the infection, which can require medical attention. While rare, some can experience life-threatening complications, which typically occur when the Salmonella infection moves beyond the intestines and into other parts of the body. Most people do not need to seek medical attention for a Salmonella infection, however, there are times when you should call your healthcare provider. For example, if you experience symptoms that last longer than just a few days, develop a fever, or begin to notice signs of dehydration, you should reach out to your medical provider at once. The FDA urges consumers not to eat any product that they suspect is a part of the recall. Instead, safely dispose of it or return it to the point of purchase. If you have questions about this recall and your personal medical risk, you should contact your doctor for more information. You Might Also Like Can Apple Cider Vinegar Lead to Weight Loss? Bobbi Brown Shares Her Top Face-Transforming Makeup Tips for Women Over 50
